top of page

News

2.2favorite.png

nGyn Secures FDA Approval in USA

May 2022

NSV's cervical cancer screening device, nGyn, received FDA approval in the United States. The NSV nGyn system is a Class II FDA Exempt Device under the PTZ designation for use as a digital colposcope. NSV's manufacturing is compliant with the latest ISO and GMP standards required by the FDA.

Try it for free

bottom of page